Bioscience

Corgenix announces CE Mark notification for Lassa fever diagnostic test

Corgenix announces CE Mark notification for Lassa fever diagnostic test

DENVER-- Corgenix Medical Corporation (OTC BB: CONX), a global developer and marketer of diagnostic tests for cardiovascular disease, liver biomarkers and emerging pathogens and lethal viruses,... Read More

By: Steve Tuesday May 14, 2013 0 comments Tags: CE Mark, Corgenix, Denver, Douglass Simpson, Lassa fever

TYRX: Study shows significant decline in cardiac infections with antibacterial envelope

TYRX: Study shows significant decline in cardiac infections with antibacterial envelope

DENVER - TYRX Inc . said its AIGISRx Antibacterial Envelope significantly reduced device infection rates in patients at high risk for device infection who received cardiovascular implantable... Read More

By: Steve Monday May 13, 2013 0 comments Tags: Denver, Dr. Suneet Mittal, Heart Rhythm 2013, TYRX

CSU-led study shows expected Supreme Court ban on gene patents may not have dramatic impact

CSU-led study shows expected Supreme Court ban on gene patents may not have dramatic impact

FORT COLLINS - A study led by Colorado State University is being considered in an expected landmark Supreme Court decision this summer on gene patents. Plaintiffs in a case filed against Myriad... Read More

By: Steve Friday May 10, 2013 0 comments Tags: biotechnology, Fort Collins, gene patents, Gregory Graff, Myriad Genetics, U.S. Supreme Court

University of Colorado signs exclusive agreement with Syndax to license cancer treatment

University of Colorado signs exclusive agreement with Syndax to license cancer treatment

AURORA - The University of Colorado announced it has signed an exclusive, worldwide licensing agreement with Waltham,Mass.-based Syndax Pharmaceuticals , a company focused on the development of... Read More

By: Steve Friday May 10, 2013 0 comments Tags: Arlene Morris, Aurora, CU Cancer Center, E-cadherin, Paul Bunn, Syndax

SomaLogic technology used to discover protein that reverses age-related cardiac hypertrophy

SomaLogic technology used to discover protein that reverses age-related cardiac hypertrophy

BOULDER - Scientists from SomaLogic were among a team of researchers led by the Harvard Stem Cell Institute that discovered a circulating protein that can reverse age-related cardiac... Read More

By: Steve Friday May 10, 2013 0 comments Tags: Boulder, Richard T. Lee, SomaLogic, SOMAscan

Inviragen to be acquired by Takeda Pharmaceutical for up to $250 million

Inviragen to be acquired by Takeda Pharmaceutical for up to $250 million

FORT COLLINS - Inviragen Inc . will be acquired by Osaka, Japan-based Takeda Pharmaceutical Company Ltd. for an upfront cash payment of $35 million and future payments of up to $215 million linked... Read More

By: Steve Wednesday May 8, 2013 0 comments Tags: DENVax, Dr. Dan Stinchcomb, Fort Collins, Inviragen

Fluonic sees market opportunity with infusion therapy pump technology

Fluonic sees market opportunity with infusion therapy pump technology

By Steve Porter InnovatioNews BOULDER - The delivery of drugs into the body through infusion therapy is one of the cornerstones of medicine, as most anyone who's been hospitalized can... Read More

By: Steve Monday May 6, 2013 0 comments Tags: Amir Genosar, Boulder, Fluonic, infusion therapy, Seth Miller, SURE+